iHuman Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for iHuman.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Entertainment earnings growth26.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Analysts Expect iHuman Inc. (NYSE:IH) To Breakeven Soon

May 02
Analysts Expect iHuman Inc. (NYSE:IH) To Breakeven Soon

Recent updates

Some Investors May Be Worried About iHuman's (NYSE:IH) Returns On Capital

Jan 30
Some Investors May Be Worried About iHuman's (NYSE:IH) Returns On Capital

iHuman Inc.'s (NYSE:IH) Business And Shares Still Trailing The Market

Dec 30
iHuman Inc.'s (NYSE:IH) Business And Shares Still Trailing The Market

Why We Like The Returns At iHuman (NYSE:IH)

Oct 13
Why We Like The Returns At iHuman (NYSE:IH)

iHuman Moves Through Economic Uncertainty In Robotic Holding Pattern

Sep 26

iHuman Inc.'s (NYSE:IH) 26% Share Price Surge Not Quite Adding Up

Jul 29
iHuman Inc.'s (NYSE:IH) 26% Share Price Surge Not Quite Adding Up

iHuman Leaves Investors Unimpressed With Flat Margins, Slow Revenue Growth

Jun 23

Operating In The Shadows Of Education Crackdown, iHuman Nears Profit Milestone

Dec 14

iHuman (NYSE:IH) May Have Issues Allocating Its Capital

Dec 09
iHuman (NYSE:IH) May Have Issues Allocating Its Capital

iHuman ADS Non-GAAP EPADS of $0.11, revenue of $35.4M

Dec 08

iHuman Is Inhumanly Undervalued

Oct 03

iHuman ADS GAAP EPS of $0.07, revenue of $34.4M

Sep 22

Is iHuman Inc. (NYSE:IH) Trading At A 34% Discount?

Jun 09
Is iHuman Inc. (NYSE:IH) Trading At A 34% Discount?

iHuman ADS reports Q1 results

Jun 08

Analysts Expect iHuman Inc. (NYSE:IH) To Breakeven Soon

May 02
Analysts Expect iHuman Inc. (NYSE:IH) To Breakeven Soon

What Type Of Shareholders Make Up iHuman Inc.'s (NYSE:IH) Share Registry?

Feb 28
What Type Of Shareholders Make Up iHuman Inc.'s (NYSE:IH) Share Registry?

iHuman ADS EPS misses by $0.01, beats on revenue

Dec 02

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as iHuman has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NYSE:IH - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20231,018181N/AN/AN/A
9/30/20231,028183N/AN/AN/A
6/30/20231,018171N/AN/AN/A
3/31/20231,008150N/AN/AN/A
12/31/2022986110182188N/A
9/30/202296366N/AN/AN/A
6/30/2022970-11N/AN/AN/A
3/31/2022961-31N/AN/AN/A
12/31/2021945-37638N/A
9/30/2021896-83N/AN/AN/A
6/30/2021794-38N/AN/AN/A
3/31/2021681-37N/AN/AN/A
12/31/2020532-48207223N/A
9/30/2020404-1N/AN/AN/A
6/30/2020312-5106116N/A
3/31/2020251-145N/AN/AN/A
12/31/2019219-2764043N/A
12/31/2018132-18-5-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if IH's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if IH's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if IH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if IH's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if IH's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IH's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.